JFCCX | VFFSX | JFCCX / VFFSX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 10 years | 8 years | - |
Gain YTD | 26.467 | 25.751 | 103% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 5000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 602M | 1.28T | 0% |
Annual Yield % from dividends | 0.00 | 1.33 | - |
Returns for 1 year | 37.90 | 33.19 | 114% |
Returns for 3 years | 15.84 | 27.90 | 57% |
Returns for 5 years | 92.47 | 91.84 | 101% |
Returns for 10 years | 135.43 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BRUJX | 17.69 | N/A | N/A |
MFS Blended Research Value Equity R1 | |||
GARSX | 9.93 | N/A | N/A |
Goldman Sachs Global Rl Estt Secs Instl | |||
CMVYX | 15.13 | -0.03 | -0.20% |
Columbia Select Mid Cap Value Instl 3 | |||
MINIX | 43.63 | -0.38 | -0.86% |
MFS International Intrinsic Value I | |||
FBTDX | 133.88 | -1.84 | -1.36% |
Franklin Biotechnology Discovery C |